Abstract

ObjectiveTo predict vascular endothelial growth factor (VEGF) expression in patients with diffuse gliomas using radiomic analysis.Materials and methodsPreoperative magnetic resonance images were retrospectively obtained from 239 patients with diffuse gliomas (World Health Organization grades II–IV). The patients were randomly assigned to a training group (n = 160) or a validation group (n = 79) at a 2:1 ratio. For each patient, a total of 431 radiomic features were extracted. The minimum redundancy maximum relevance (mRMR) algorithm was used for feature selection. A machine-learning model for predicting VEGF status was then developed using the selected features and a support vector machine classifier. The predictive performance of the model was evaluated in both groups using receiver operating characteristic curve analysis, and correlations between selected features were assessed.ResultsNine radiomic features were selected to generate a VEGF-associated radiomic signature of diffuse gliomas based on the mRMR algorithm. This radiomic signature consisted of two first-order statistics or related wavelet features (Entropy and Minimum) and seven textural features or related wavelet features (including Cluster Tendency and Long Run Low Gray Level Emphasis). The predictive efficiencies measured by the area under the curve were 74.1% in the training group and 70.2% in the validation group. The overall correlations between the 9 radiomic features were low in both groups.ConclusionsRadiomic analysis facilitated efficient prediction of VEGF status in diffuse gliomas, suggesting that using tumor-derived radiomic features for predicting genomic information is feasible.

Highlights

  • Diffuse gliomas graded from II to IV according to the World Health Organization (WHO) criteria are the most common primary malignant tumors of the brain [1]

  • Nine radiomic features were selected to generate a vascular endothelial growth factor (VEGF)-associated radiomic signature of diffuse gliomas based on the minimum redundancy maximum relevance (mRMR) algorithm

  • Feature selection and classification In the current study, an efficient feature selection tool known as the mRMR algorithm was used, and a subset of 9 features were screened from a total of 431 radiomic features

Read more

Summary

Introduction

Diffuse gliomas graded from II to IV according to the World Health Organization (WHO) criteria are the most common primary malignant tumors of the brain [1]. Tumor cells with high expression of VEGF often result in poor prognosis and short survival [4]. VEGF is a well-known biomarker that is of great significance in the development of tumors, and it is a promising target in the treatment of gliomas, especially recurrent glioblastomas (GBM) [4,5,6]. Antiangiogenic therapies, such as bevacizumab, have been proved to increase progression-free survival in patients with

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call